Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    17517240 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Respiratory Distress Syndrome (RDS);   Sepsis;   Pneumonia;   Hypertension, Pulmonary
Interventions: Drug: Inhaled nitric oxide;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.